ARCHIVES

Charles Moertel, Mayo Clinic Investigator, Advocate Of Rigorous Trials, Dead At 66

This article is from The Cancer Letter archive.

Vol. 20 No. 27 | July 8, 1994

Download PDF Visit The Full Archive

Related Articles

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

Device Shortens Time To Make T Cells For Immunotherapy

March 27, 2009

Seven Seats Open Up On NCAB

January 17, 1986

In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List

December 2, 1983

Preventive Ovarian Surgery Recommended For Women with BRCA1 Mutations by Age 35

February 28, 2014

Groups Offer Revisions to Kennedy-Hutchison Bill

May 15, 2009